StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

<< Previous

Bullboard Posts

Next >>

Post by kodiakupon Jan 20, 2021 9:14pm

194 Views

Post# 32341523

House Positions for C:SZLS.WS from 20201220 to 20210120

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
2 RBC	192,500	51,298	0.266	0			192,500	-51,298
80 National Bank	20,000	6,800	0.34	0			20,000	-6,800
19 Desjardins	38,100	7,685	0.202	21,000	5,500	0.262	17,100	-2,185
74 GMP	15,000	4,800	0.32	0			15,000	-4,800
124 Questrade	3,600	1,255	0.349	0			3,600	-1,255
5 Penson	1,500	475	0.317	1,000	275	0.275	500	-200
7 TD Sec	700	200	0.286	425	96	0.226	275	-104
22 Fidelity	0			13,250	4,561	0.344	-13,250	4,561
33 Canaccord	9,825	2,430	0.247	42,350	12,985	0.307	-32,525	10,555
76 Industrial Alliance	0			96,200	15,503	0.161	-96,200	15,503
1 Anonymous	90,500	16,191	0.179	197,500	52,216	0.264	-107,000	36,025
TOTAL	371,725	91,134	0.245	371,725	91,136	0.245	0	2